Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTitan Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Titan Pharmaceuticals, Inc. Earnings Date And Information
Titan Pharmaceuticals, Inc. last posted its earnings results on Friday, March 31st, 2023. The company reported $-2.20165 earnings per share for the quarter, topping analysts' consensus estimates of $-4.4 by $2.19835. The company had revenue of 0 for the quarter and had revenue of 184,000 for the year. Titan Pharmaceuticals, Inc. has generated $-7 earnings per share over the last year ($-7.41 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Titan Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Titan Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 01/03/2025 | Q3 2024 | -$0.83 | $0 | $0 | ||
| 08/15/2024 | Q2 2024 | -$2.29 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$1.24 | $0 | |||
| 04/01/2024 | Q4 2023 | -$2.52 | $81,000 | |||
| 11/14/2023 | Q3 2023 | -$0.45 | $4,000 | |||
| 08/14/2023 | Q2 2023 | -$2.11 | $1,000 | |||
| 05/15/2023 | Q1 2023 | -$2.20 | $98,000 | |||
| 03/31/2023 | Q4 2022 | -$4.40 | $0.00 | $51,000 | ||
| 11/14/2022 | Q3 2022 | -$4.20 | -$3.61 | 0.59 | $4,000 | |
| 08/11/2022 | Q2 2022 | -$5.20 | -$0.18 | 5.02 | $150,000 | |
| 05/16/2022 | Q1 2022 | -$0.24 | $192,000 | |||
| 03/25/2022 | Q4 2021 | -$7.00 | -$0.26 | 6.74 | $135,000 | |
| 11/15/2021 | Q3 2021 | -$0.35 | -$0.19 | 0.16 | $1.09 M | $264,000 |
| 08/16/2021 | Q2 2021 | -$0.35 | -$0.17 | 0.18 | $1.00 M | $445,000 |
| 05/17/2021 | Q1 2021 | -$0.85 | -$0.28 | 0.57 | $682,000 | |
| 03/31/2021 | Q4 2020 | -$1.33 | -$0.33 | 1 | $1.06 M | |
| 11/16/2020 | Q3 2020 | -$24.02 | -$1.51 | 22.51 | $1.00 M | $1.12 M |
| 08/14/2020 | Q2 2020 | -$18.02 | -$1.47 | 16.55 | $823,000 | $1.33 M |
| 05/15/2020 | Q1 2020 | -$2.03 | $1.34 M | |||
| 03/30/2020 | Q4 2019 | -$0.08 | -$1.43 | -1.35 | $1.22 M |
Titan Pharmaceuticals, Inc. Earnings: FAQ's
When is Titan Pharmaceuticals, Inc.'s earnings date?
Titan Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
Did Titan Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Titan Pharmaceuticals, Inc. (:TTNP) reported $-2.20165 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.4 by $2.19835.
How can I listen to Titan Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Titan Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Titan Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Titan Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does Titan Pharmaceuticals, Inc. generate each year?
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded annual revenue of $184,000.
How much profit does Titan Pharmaceuticals, Inc. generate each year?
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded net income of $184,000. Titan Pharmaceuticals, Inc. has generated $-7.41 earnings per share over the last four quarters.
What is Titan Pharmaceuticals, Inc.'s price-to-earnings ratio?
Titan Pharmaceuticals, Inc. (:TTNP) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is 0.08.